Timothy Ramdeen
Direktor/Vorstandsmitglied bei ONCONETIX, INC.
Vermögen: - $ am 30.04.2024
Profil
Timothy R.
Ramdeen is the founder of Amplexd Therapeutics LLC (founded in 2022) and Dharma Capital Advisors (founded in 2022), where he holds the title of Managing Partner.
He is currently working as an Independent Director at Onconetix, Inc. (since 2023) and as the President of Sixth Borough Capital Fund LP.
In his former positions, he served as an Independent Director at Blue Water Biotech, Inc. and as the Chief Investment Officer at Sixth Borough Capital Management LLC (from 2021 to 2022).
Mr. Ramdeen completed his undergraduate degree at Temple University (Pennsylvania) in 2013 and obtained an MBA from The Leonard N Stern School of Business in 2019.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ONCONETIX INC
-.--% | 05.04.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Timothy Ramdeen
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCONETIX, INC. | Direktor/Vorstandsmitglied | 01.01.2023 |
Sixth Borough Capital Fund LP
 Sixth Borough Capital Fund LP Investment ManagersFinance Sixth Borough Capital Fund LP is a private equity fund that operates to provide investment opportunities to its clients. The private company is based in Boca Raton, FL. The CEO of the company is Robert Keyser. | Präsident | - |
Ehemalige bekannte Positionen von Timothy Ramdeen
| Unternehmen | Position | Ende |
|---|---|---|
Sixth Borough Capital Management LLC
 Sixth Borough Capital Management LLC Investment ManagersFinance Sixth Borough Capital Management LLC (Sixth Borough) is an independent hedge fund management firm headquartered in New York City. The firm was founded by Timothy R. Ramdeen in 2021. Sixth Borough provides investment advice to high net worth clients. | Chief Investment Officer | 01.03.2022 |
| Amplexd Therapeutics LLC | Gründer | - |
Blue Water Biotech, Inc.
 Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Direktor/Vorstandsmitglied | - |
Ausbildung von Timothy Ramdeen
| Temple University (Pennsylvania) | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Sixth Borough Capital Fund LP
Sixth Borough Capital Fund LP Investment ManagersFinance Sixth Borough Capital Fund LP is a private equity fund that operates to provide investment opportunities to its clients. The private company is based in Boca Raton, FL. The CEO of the company is Robert Keyser. | Finance |
Sixth Borough Capital Management LLC
Sixth Borough Capital Management LLC Investment ManagersFinance Sixth Borough Capital Management LLC (Sixth Borough) is an independent hedge fund management firm headquartered in New York City. The firm was founded by Timothy R. Ramdeen in 2021. Sixth Borough provides investment advice to high net worth clients. | Finance |
Blue Water Biotech, Inc.
Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Health Technology |
| Amplexd Therapeutics LLC |
